Relmada Therapeutics
RLMD
RLMD
44 hedge funds and large institutions have $1.68M invested in Relmada Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
71% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 14
Holders
44
Holding in Top 10
–
Calls
$20K
Puts
–
Top Buyers
| 1 | +$32.6K | |
| 2 | +$24.1K | |
| 3 | +$18.2K | |
| 4 |
HF
HRT Financial
New York
|
+$14K |
| 5 |
Two Sigma Investments
New York
|
+$11.6K |
Top Sellers
| 1 | -$340K | |
| 2 | -$104K | |
| 3 | -$76K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$65K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$52.1K |
